<DOC>
	<DOCNO>NCT01134939</DOCNO>
	<brief_summary>The question prompt study extent result clinical trial translate everyday practice ( external validity ) . First foremost question tolerability efficacy antiretroviral combination treatment Viramune antiretroviral partner . In particular , adverse event record depend gender therapeutic effect monitor via course viral load improvement immune system , base CD4 cell count .</brief_summary>
	<brief_title>Non-interventional Observational Study With ViramuneÂ® HIV Evaluate Gender Specific Data</brief_title>
	<detailed_description>Time Perspective : retro- prospective</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Nevirapine</mesh_term>
	<criteria>Inclusion criterion : The inclusion criterion treatment Viramune plus antiretroviral combination drug base current Information Healthcare Professionals/SPC Exclusion criterion : The inclusion criterion treatment Viramune plus antiretroviral combination drug base current Information Healthcare Professionals/SPC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>